Mondobiotech Holding Ag Basel - Business Overview - RLFTF Stock
Relief Therapeutics Holding SA is a biopharmaceutical company established in 2013. The headquarters of this company is established in Gevena, Switzerland. This company is engaged in exploring top therapeutic products that provide quick relief to all patients from serious diseases. It fulfills the high medical needs of different countries, including North America, Switzerland and Europe.
Moreover, the firm is performing its operations with highly efficient team members. They are highly committed to their work and focus on multiple clinical-stage programs based on the molecules. Relief Therapeutics is making success and recognition in the market by completing several projects in time. It plays an important role in the biotechnological sectors by contributing a lot.
This firm holds a wide range of outstanding shares named RLFTF Stock. With a widely spread network, the company is ethically running its operations. It has big subsidiaries, including AdVita life science GmbH, Siena Biotech. They are developing products to cure rare and neglected diseases using peptides and immune-modulated materials.
They are engaged in developing multiple products under the strict vigilance of managers. All the corporate governance looks seriously into each and eerie matter of the company. It is coving the healthcare and biotechnological industrial sectors. It uses different leading compounds to manufacture products to cure diseases like lung injury, respiratory syndrome, pulmonary diseases, chronic Beryllium disease.
Do you want to explore the pricing level and fluctuations regarding RLFTF Stock? If yes, then continue reading this article and explore more. Hence make good investment decisions and much more.
Current Stock Price:
The current price of RLFTF Stock is 0.036 US dollars. In the recent five days, the price was 0.037 US dollars on July 28, 2022, and 0.039 US dollars on July 29, 2022.
Stock Volatility or Stability:
The stock was highly volatile, with a price of 0.62 US dollars on August 7, 2020. The value of RLFTF Stock was 0.59 US dollars on August 21, 2020. Other dates where the stock is highly stable are:
- August 28, 2020.
- September 11, 2020.
- January 21, 2021.
- October 16, 2019.
- September 4, 2021.
Maximum Stock Price in the Last Five Years:
The maximum price of this stock in the previous five years was 0.62 US dollars on August 7, 2020.
Minimum Stock Price in the Last Five Years:
The minimum price of RLFTF Stock in the previous five years was 0.030 on June 10, 2022.
Financial Statements Analysis:
The financial statement analysis of any company tells the financial condition of the company. It includes reviewing and analyzing of company's financial statements to make a better economic decision.
Hence the financial statement analysis of Relief Therapeutics company is given below. Let's have a look at that.
The historical annual earnings are declined to 26.6% per year over the past five years. At the end of 2021, the earnings are -36.21 million US dollars.
The forecasted annual revenue growth is 53.2%. At the end of the year 2021, the revenues are zero percent, while the total revenue is 15.65 k Us dollars in 2017.
Debt to Equity:
The debt to equity ratio of this company has reduced from 3.9% to 1% over the past five years. The value of debt was 1.82 million US dollars at the end of 2021. Moreover, the equity value is 189.40 US dollars in the year 2021.
The short-term liabilities are worth 20.87 million US Dollars, and the long-term liabilities are worth 52.17 million US dollars.
All the short-term assets worth 57.38 million US dollars cover the short-term liabilities, and the long-term assets with a value of 205.54 cover the long-term liabilities.